Bausch Health Companies Inc opened trading today at $13.78 and closed at $14.15. Intraday prices ranged from a low of $13.75 to a high of $14.24.

The price advanced 3.82% from the previous day's close of $13.63.

During the day across North America, the TSX Composite closed -0.27% at 22051.79, the S&P 500 closed -1.23% at 5147.21, the Dow Jones Industrial Average closed -1.35% at 38596.98 and the Nasdaq Composite closed -1.40% at 16049.08.

Bausch Health Companies Inc traded under BHC on the Toronto Stock Exchange (TSX).

A total of 377,608 shares was traded during the session, with total trades of 2,866. On average, Bausch Health Companies Inc has traded 411,028 shares over the last 5-days and 339,968 year-to-date.

The TSX overall saw 2,800 price advancers against 2,386 declines and 147 unchanged.

During the prior 52 weeks, BHC.TO has traded as high as $15.43 (April 03,2024) and low as $7.56 (May 12,2023). Moreover, in the last 12 months, Bausch Health Companies Inc's shares have advanced 41.78%, while they have boosted 33.11% year-to-date.

It announced a 1.00 dividend on November 05/10, with an November 10/10 ex-date and December 22/10 pay day.

Following today's trading, Bausch Health Companies Inc has a market capitalization of $4.98 billion on a float of 365,412 shares outstanding. Its annual EPS is $-1.62.

Bausch Health Companies Inc is a TSX Drug Specialty & Generic company headquartered in Laval, CAN.

Currently, Bausch Health Companies Inc has an average recommendation of "Hold" based on 6.00 analysts according to Zacks. Currently, there are 1 buy ratings, 1 sell ratings and 4 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..